Quote | Ensysce Biosciences Inc. (NASDAQ:ENSC)
Last: | $0.5583 |
---|---|
Change Percent: | -1.66% |
Open: | $0.55 |
Close: | $0.5583 |
High: | $0.567999 |
Low: | $0.541 |
Volume: | 43,894 |
Last Trade Date Time: | 04/23/2024 03:00:00 am |
News | Ensysce Biosciences Inc. (NASDAQ:ENSC)
2024-03-18 11:13:32 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Fisker (NYSE: FSR ) stock is moving on Monday after the electric vehicle (EV) company announced that it has secured an additional $150 million in funding . According to a pr...
2024-03-18 10:53:13 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Ensysce Biosciences (NASDAQ: ENSC ) just reported results for the fourth quarter of 2023. Ensysce Biosciences reported earnings per share of -$1.13. This was below the ana...
Message Board Posts | Ensysce Biosciences Inc. (NASDAQ:ENSC)
Subject | By | Source | When |
---|---|---|---|
nsysce Biosciences Announces Successful Completion of Ground-Breaking Study | subslover | investorshub | 05/09/2023 1:27:57 PM |
Time for a bounce? | PennyPusher786 | investorshub | 05/04/2023 7:09:57 PM |
$ENSC great article | PennyPusher786 | investorshub | 05/04/2023 3:41:14 PM |
news out | Shift-4 | investorshub | 04/30/2023 8:47:52 PM |
should we be shorting? | Hercules1 | investorshub | 04/29/2023 5:04:07 PM |
News, Short Squeeze, Breakout and More Instantly...
Ensysce Biosciences Inc. Company Name:
ENSC Stock Symbol:
NASDAQ Market:
Corporate Update Call to be Held Thursday, March 21, 2024 at 11:00am ET to Discuss Recent FDA Breakthrough Therapy Designation and Phase 3 Clinical Plans SAN DIEGO, CA / ACCESSWIRE / March 15, 2024 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC), a clinical-stage compa...